Defective free-fatty acid oxidative glucose metabolism IDDM hypoglycemia Influence glycemic control impact diabetes treatment plasma free-fatty acid FFA oxidative fuel metabolism hypoglycemia indirect calorimetry glucose low-dose insulin infusion plasma insulin basal well-controlled insulin-dependent diabetes IDDM patients healthy subjects Diabetic subjects insulin euglycemia study free-insulin levels counterregulatory hormone responses similar plasma fall pronounced well-controlled diabetic subjects well-controlled diabetic healthy subjects small increment insulin plasma FFA fat oxidation stimulated carbohydrate oxidation contrast FFA levels diabetic subjects glucose oxidation resistance antilipolytic effect insulin occurs absence hypoglycemic counterregulation sequential low-dose euglycemic insulin clamp healthy subjects plasma FFA insulin dose contrast FFA diabetic subjects insulin dose insulin dose-response curve suppression plasma FFA normal well-controlled subjects IDDM diabetic patients resistant antilipolytic effects insulin show impaired stimulation glucose oxidation insulin-induced hypoglycemia Amelioration defects well-controlled patients factor risk hypoglycemia intensified insulin therapy 